ClearSky Health has awarded ClearSky Rehabilitation Hospital of Rio Rancho with the organization’s annual Clinical Advancement Award in recognition of the hospital’s clinical outcomes.
The hospital is part of ClearSky Health, a rehabilitative healthcare provider that owns and operates medical rehabilitation hospitals in Texas, Louisiana and New Mexico, with plans to open new facilities in Arizona, Kansas, Ohio, Wisconsin, Florida, and additional locations in Texas, according to the announcement of the award.
ClearSky Health recognized ClearSky Rio Rancho for its clinical outcomes based upon the Performance Evaluation Model (PEM), the announcement said.
PEM scores are national clinical indicators used by the Uniform Data System for Medical Rehabilitation, an organization that administers the largest medical rehabilitation database in the world. PEM scores are ranked on quality patient care that is effective, efficient, timely, and patient-centered. ClearSky Rio Rancho improved its PEM score the most this past year from among the hospitals within ClearSky Health.
“To increase PEM indicator scores takes a daily concentrated effort in ensuring patients are receiving high-quality rehabilitative treatments,” said Nate Miller, senior VP of ClearSky Health.
“Our staff is passionate about providing quality patient care,” said Shawn Wilbur, CEO of ClearSky Rio Rancho. “They set goals individually with each patient and offer specialized treatments to make our patients’ recoveries as successful as possible.”
The award, she said, “reflects the exceptional care provided by our team and the amazing outcomes we’re able to deliver to members of our community who need our help to get back their independence.”
ClearSky Rehabilitation Hospital of Rio Rancho is a 36-bed hospital that provides specialized rehabilitative services to patients who live with disabling injuries or illnesses, such as strokes, brain injuries, hip fractures, spinal injuries, Parkinson’s disease, multiple sclerosis, or other medically-complex conditions such as COVID-19.